The fifth edition of IBS Days delved into the latest developments in IBS research and clinical management. This article aims to explore causes that can be misdiagnosed as IBS and non-pharmacological strategies targeting gut barrier and gut microbiome dysfunction.
Crohn’s disease is an inflammatory bowel disease linked to an imbalance in the gut microbiome. Now, researchers at McMaster University have found in mice a way to target and 'turn off' only the bad gut bacteria using specially trained, precision viruses. This breakthrough paves the way for treatments tailored to each patient.
Species-level, food-specific associations predicted in a cohort of 10,068 people may guide personalized nutrition
6 Jul 2026by Andreu Prados
While diet is a major determinant of the human gut microbiome, little is known about diet-microbiome associations at species-level resolution. New findings from the Human Phenotype Project found species-level, food-specific associations validated at population scale that might guide personalized nutrition.
One in four adults experience digestive symptoms that impact quality of life
15 Jun 2026by Andreu Prados
Digestive symptoms with an impact on quality of life (QoL) affect one in four adults in the general population worldwide who do not qualify for a diagnosis of a Disorder of Gut-Brain Interaction (DGBI). Recent research suggests this ‘sub-diagnostic’ group demands additional investigation and might benefit from targeted interventions, including dietary interventions.
From diet to microbiome therapies: Key insights from the GMFH Summit 2026
19 May 2026by Manon Oliero, Giovana Martucelli, Andreu Prados
The 14th edition of the Gut Microbiota for Health World Summit brought together leading researchers from around the world to present the latest advances in the field. The meeting reinforced clinical practices that have become increasingly established in recent years and also presented unpublished results on new microbiome-targeted therapies, in line with the summit’s central theme: “Diet and other ways to manipulate the gut microbiome in clinical practice.”
GMFH World Summit 2026: Diet and other ways to manipulate the gut microbiome in clinical practice
14 May 2026by Andreu Prados
With nearly 240 participants from 27 countries, the 14th edition of GMFH World Summit covered basic, translational and clinical science supporting the integration of microbiome-targeted interventions into preventive and therapeutic strategies for gastrointestinal disorders, cardiometabolic diseases, and cancer.
A global consensus establishes a basis for measuring and improving gut health
6 Apr 2026by Andreu Prados
While “gut health” is becoming a popular term, mainly in media and marketing claims but also in the clinical context, researchers have not yet nailed down a definition. Now, a global group of 13 scientists and clinicians updates a consensus definition of gut health and implications from bench to bedside.
The ins and outs of the new Dietary Guidelines for Americans in light of the gut microbiome
25 Feb 2026by Andreu Prados
The 2025-2030 Dietary Guidelines for Americans recognize the role of the microbiome for health. This article delves into both strengths and inconsistencies of the new guidelines through the gut microbiome lens.
There is a lack of evidence for high-fiber diets to manage constipation. Here’s what works
9 Feb 2026by Andreu Prados
Chronic constipation affects around one in ten adults worldwide. The new British Dietetic Association’s guidelines suggest shifting from generic high-fiber diets to specific foods and drinks to improve constipation.
Specific probiotic species and strains could help manage chronic constipation in adults
2 Feb 2026by Andreu Prados
Chronic constipation affects around one in ten adults worldwide. The new British Dietetic Association’s guidelines show that psyllium, certain probiotic strains and magnesium oxide supplements can help to improve constipation.
